ANISIMOVA, O. S.;SHEJNKER, YU. N.;DYACHKOVA, S. N.;PATEYUK, T. D.;KULESHO+, ANAL. METODY KONTROLYA V RAZRAB. I PR-BE SINTET. LEKARSTV. PREPARATOV, MO+
作者:ANISIMOVA, O. S.、SHEJNKER, YU. N.、DYACHKOVA, S. N.、PATEYUK, T. D.、KULESHO+
DOI:——
日期:——
WOLINSKI J.; ILCZUK A., ACTA POL. PHARM. <APPH-AX>, 1975, 32, NO 3, 307-310
作者:WOLINSKI J.、 ILCZUK A.
DOI:——
日期:——
WOLINSKI J.; ILCZUK A., ACTA POL. PHARM. <APPH-AX>, 1976, 33, NO 2, 141-143
作者:WOLINSKI J.、 ILCZUK A.
DOI:——
日期:——
[EN] INHIBITORS OF FLAVIVIRIDAE VIRUSES<br/>[FR] INHIBITEURS DE VIRUS FLAVIVIRIDAE
申请人:GILEAD SCIENCES INC
公开号:WO2011011303A1
公开(公告)日:2011-01-27
Provided are compounds of Formula I: (I) and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
[EN] MORPHOLINE COMPOUND<br/>[FR] COMPOSÉ DE MORPHOLINE<br/>[JA] モルホリン化合物